Tag: bortezomib weekly

#VisualAbstract Administering bortezomib on a weekly basis VS twice weekly basis does not significantly affect progression-free survival (PFS) or overall survival (OS) in Vrd first-line therapy for multiple myeloma (bortezomib, lenalidomide, and dexamethasone)

byKathleen Lau

January 1, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Seventh cervical nerve neurotomy may augment speech therapy in patients with chronic aphasia post-stroke
Time-restricted eating does not confer changes in sleep, mood, or quality of life
Commonly cited medication triggers may not increase risk of microscopic colitis among older adults

No Result

View All Result